Chief, Global Clinical Operations Excellence (Equity)

BeOne Medicines; United States; On-site; USD 272,000 - 352,000; Full time

Job summary

BeOne Medicines seeks a senior leader to join the GCO Leadership team, shaping clinical development strategies and driving quality/compliance globally. You will lead eTMF, SOPs, and training, while building a high-capacity team to optimize trial operations across regions.

Essential: 15+ years in biotech/pharma/CRO with strong GCP/QA experience, plus proven leadership, CAPA management, and risk-based process improvements. Travel up to 25% is expected as part of global trials.

Qualifications

• Fluent in English with strong written and verbal communication.
• Proven leadership experience in global clinical operations and quality.
• Track record implementing GCP quality systems and CAPA programs.

Responsibilities

• Lead development and governance of clinical development & GCO strategies.
• Build and mentor multi-national teams aligning with GCO goals.
• Oversee eTMF, SOPs, training plans, and continuous process improvement.
• Drive KPIs/KQIs reporting and compliance with ICH, FDA, EMA, and PMDA.
• Partner with QA and Corporate Compliance to close CAPAs and audits.

Skills

Leadership

Quality systems

CAPA management

Project management

Root cause analysis

Six Sigma

LEAN

Agile methodologies

Risk management

Education

BS degree in science/healthcare field

15+ years in biotech/pharma/CRO related to Clinical Operations/QA

Tools

Microsoft Office Suite (Word/Excel/PowerPoint/Outlook)

Job description

BeOne Medicines seeks a senior leader to join the GCO Leadership team, shaping clinical development strategies and driving quality/compliance globally. You will lead eTMF, SOPs, and training, while building a high-capacity team to optimize trial operations across regions.

Essential: 15+ years in biotech/pharma/CRO with strong GCP/QA experience, plus proven leadership, CAPA management, and risk-based process improvements. Travel up to 25% is expected as part of global trials.